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THE EFFECT OF PROPOFOL ON THE CANINE
SPHINCTER OF ODDI
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To assess the effect of propofol on the canine sphincter of Oddi (SO), sphincter of Oddi manometry (SOM)
was performed in fasting dogs which had undergone cholecystectomy and placement of modified Thomas
duodenal cannulae. Using two water-perfused, single-lumen manometric catheters, SO and duodenal
pressures were measured simultaneously. Baseline SO activity was recorded for at least one complete
interdigestive cycle followed by bolus injections of propofol (Diprivan(R)) (N 31) from 0.1 to 4.0 mg/kg
during Phase of the Migrating Motor Complex (MMC).
When propofol was administered in bolus doses < 0.5 mg/kg, no change in SO or duodenal motor
function was seen. In doses > 0.5 mg/kg, SO basal pressure, amplitude, and frequency of contractions
increased significantly. Increases in duodenal activity paralleled SO activity. Our results suggest that
propofol in low doses may be useful for sedation during Sphincter ofOddi manometry in humans. Further
studies of the effects of propofol on the human sphincter of Oddi are warranted.
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INTRODUCTION
Sphincter of Oddi manometry (SOM) during endoscopic retrograde cholangiopan-
creatography (ERCP) is increasingly performed in the evaluation of post-cholecystec-
tomy pain, allowing identification of a subset of patients with sphincter of Oddi
dysfunction who respond to sphincterotomy2. Although conscious sedation during
diagnostic and therapeutic ERCP is usually achieved with a combination of a benzo-
diazepine and an opiate, opiate analgesics have been shown to alter SO pressures3’’
and may prevent accurate measurement ofSO pressure. To date, diazepam (Valium(R))
is the only sedative-hypnotic recommended for conscious sedation during SOM, since
it has been demonstrated not to affect SO motility3’5. However, many patients are
inadequately sedated during SOM using diazepam alone. Thus, the ideal sedative-
hypnotic for use during SOM should provide adequate sedation without altering SO
pressure or motility.
Propofol (Diprivan(R)) is a new sedative-hypnotic agent producing dose-dependent
depression of the central nervous system similar to that of barbiturates and ben-
zodiazepines6-a. Propofol (2, 6 di-isopropylphenol), an alkylphenol, is structurally
* Address correspondence to: Todd H. Baron, M.D, Division of Gastroenterology 633 ZRB, University
Station, Birmingham, AL, U.S.A. 35294.
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unrelated to all other intravenous anesthetic agents9. Initially introduced as an
anesthetic induction agent, low-dose propofol has become increasingly popular as a
sedative-hypnotic agent for conscious sedationt-t2, administered by either bolus or
continuous infusion.
Various animal models have been used to define the SO responses to drugs,
hormones, and other regulatory substances. Numerous in vitro and in vivo studies
suggest the SO in dogs functions much like the human SO, both physiologically and
pharmacologically 13,14.
The purpose of this study was to determine the effects ofpropofol at various doses on
the motility of the canine SO.
MATERIALS AND METHODS
Animal Preparation
Six randomly selected dogs weighing 17-23 kg underwent cholecystectomy and place-
ment of modified Thomas duodenal cannulae centered opposite the biliary papilla as
previously described15’16. The animals were trained to stand quietly during a 6-week
recovery period.
Equipment
SO manometry was performed using a Gould transducer and paper recorder (models
13-4615-50 and 2800S, respectively) in conjunction with a pnemo-hydraulic infusion
system (Arndorfer Medical Specialities, Greendale, WI). The post-occlusion pressure
rise was 200mm Hgsec-1, and paper speed 1mm sec-1. A 5Fr, side-hole catheter
(Wilson-Cook Medical, Winston Salem, U.S.)continuously perfused with de-ionized
water at 0.25 ml/min was used for monitoring SO pressure. A 5Fr, end-hole water-
perfused catheter (Wilson-Cook) was placed into the duodenal lumen for measuring
duodenal pressure. Catheters were secured in postion using a cork in the Thomas
cannula (Figure 1).
Cannulation Technique and Materials
A 22-gauge angiocatheter was placed into the radial vein, providing access for
intravenous (i.v.) injections. After gently exposing the papilla, the manometry catheter
was inserted deeply into the common bile duct. The biliary catheter was withdrawn
slowly across the sphincter until the high pressure zone (HPZ) was located by
monitoring the pressure tracing and then maintained at a constant position through-
out the study.
Ten complete sphincter of Oddi studies were performed in conscious fasting dogs
(mean study length 5.3 hours, range 3.8-6.3 hours). Animals were supported in the
standing position using a modified Pavlov sling. One complete cycle of the MMC was
identified manometrically. All SO measurements (pre- and post-drug) were obtained
during Phase I. Sphincter of Oddi measurements included resting sphincter pressure
(basal SO pressure minus basal duodenal pressure), as well as amplitude and frequencyTHE EFFECT OF PROPOFOL 299
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Figure 1 Manometry system used for simultaneous measurement of biliary sphincter and duodenal
pressure. (From: Thompson, J. C., Greely, G. H., Rayford P. L., Townsend, C. M., (1987) Surgical Tech-
niques. In Gastrointestinal Endocrinology, p. 63. New York: McGraw-Hill, Inc., with permission.)
of phasic contractions. Measurements ofSO pressure and motility were recorded after
injection of CCK-octapeptide, 0.05 #g/kg in 3 dogs to serve as positive control.
Propofol, 10mg/ml (Diprivan(R), ICI Pharmaceuticals, Wilmington, DE), was given by
rapid i.v. bolus in incremental doses from 0.1 mg/kg to 4.0 mg/kg.
Statistical Methods
All data are expressed as mean SEM (standard error of the mean). Non-parametric
data were analyzed using the Wilcoxon sign rank test. Statistical significance was
defined as a probability level, p < 0.05.
RESULTS
In 3 of 6 animals given CCK, SO basal pressure and contractility were reduced as
expected. SO basal pressure and motility remained stable throughout the pre-drug300 T. H. BARON ET AL.
study period in all animals. Bolus doses of propofol <0.5mg/kg (mean dose
0.25 mg/kg, n 16) did not significantly change SO pressure (9.9 + 0.6mm Hg-
10.9
+__ 0.6, mean +_ SEM, p 0.2) or alter duodenal activity (Figure 2). However, doses of
propofol > 0.5 mg/kg significantly increased SO pressure, with a trend toward dose
response. Bolus doses of propofol between 0.5 and 1.0 mg/kg (mean 0.68 mg/kg, n 6)
increased SO pressure from 7.8 1.1 13.8 2.4, p 0.03; doses > 1.0mg/kg (mean
2.3 mg/kg, n 9) increased SO pressure from 6.6 _
0.9 13.8 1.8, p 0.004 (Figure
2). Bolus doses of propofol < 0.5 mg/kg had no effect on amplitude or frequency of
contractions, while doses>0.5mg/kg increased SO amplitude and frequency
(Table 1). Duodenal contractility increased concomitantly with SO contractility fol-
lowing propofol boluses of > 0.5 mg/kg. The duration of propofol’s effect on motility
was 2-5 minutes when given in doses of 0.5 to 1.0 mg/kg. Figure 3 illustrates the effects
<0.5mg/kg
Dose
T
0.5-1mg/kg >l.0mg/kg
Range of Propofol
Figure 2 The effect of propofol on the canine sphincter of Oddi at three dose ranges. Black bars represent
the pre-drug sphincter pressure; white bars represent post-drug sphincter pressure (mean __+ SEM).
Table 1 Effect of propofol on amplitude and frequency of SO contractions
Propofol (mg/kg) Amp (pre) Amp (post) Freq (pre) Freq (post)
0.1-0.45 9.8 1.1 10.7 + 1.4 10.7 + 0.9 12.2 __+ 1.0
0.5 1.0 9.5 + 0.9 17.3 2.6* 8.8 + 1.1 13.8 __+ 1.9
> 1.0 10.6 __+ 1.0 24.9 3.4* 9.0 + 0.7 15.4 __+ 1.0"
Amp amplitude (mm Hg); Freq frequency (sec- 1), p < 0.05.61q ww
0
61-I ww
o
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of low-dose propofol on the canine sphincter. At doses > 1 mg/kg duodenal and SO
contractions resembled those seen during Phase III of the MMC.
DISCUSSION
The effect of propofol on sphincter of Oddi motility is unknown. We have demon-
strated that low-dose propofol in bolus doses < 0.5 mg/kg have no effect on sphincter
of Oddi or duodenal motility in the canine. Adequate conscious sedation in humans
can be achieved with intermittent propofol boluses of less than 0.5 mg/kg (personal
communication, P.S.A. Glass, M.D., 1993). Although the canine is less sensitive to the
sedative effects ofpropofol than humans17, we observed the animals to be sedated when
repetitive bolus doses of < 0.5 mg/kg were given. Due to the redistribution characteris-
tics of the drug, cumulative effects are not seen after multiple bolus doses
or prolonged infusion.
Rosa and colleagues
is administered repeated, small boluses of propofol (0.6 mg/kg
followed by 0.3 mg/kg) during regional anesthesia. Excellent conscious sedation was
achieved without effect on central respiratory drive, gas exchange, or respiratory
pattern. Advantages of propofol include a rapid onset of action and a large volume
of distribution leading to rapid recovery9. In addition, it possesses favorable
amnestic, analgesic, and anti-emetic properties 19,20. Phlebitis occurs in less than1 of
patients21.
Propofol has been used for conscious sedation during gastrointestinal (G.I.) pro-
cedures with significantly faster recovery times than diazepam or midazolam22-25.
Dubois et al.23 used propofol by continuous infusion at a mean dose of 4.3 mg/kg/hr
for conscious sedation during 100G.I. procedures (including ERCP and sphinc-
terotomy).
In this study, higher doses of propofol significantly increased SO contractility. Since
the canine SO is entirely within the intramural segment of the duodenum26, it is
possible that SO motility was increased secondary to an increase in duodenal contrac-
tility. These changes in motility may be explained by several mechanisms. Propofol
causes vasodilation when administered in doses required for induction and main-
tenance of general anesthesia2. Using endothelial cells in vitro, Xuan et al.27 de-
monstrated that propofol interferes with intracellular calcium mobilization which
may be the mechanism for propofol induced relaxation of endothelial smooth muscle.
However, intracellular calcium release plays a minor role in gastrointestinal smooth
muscle contraction28. Propofol may shift extracellular calcium into cells, increas-
ing contractility. Additionally, sub-hypnotic doses of propofol alleviate pruritus in
cholestatic liver disease29, possibly via interaction with opioid receptors in the central
nervous system. Since opiates cause alterations in the contractility of the
SO, higher doses of propofol may alter SO contractility through interaction with
opioid receptors.
We feel propofol possesses many advantages over diazepam for conscious sedation,
including analgesic properties and rapid recovery. Studies in patients with and without
SO dysfunction are needed to determine if propofol (alone and in combination with
diazepam) has clinically significant effects on the human SO. We have demonstratedTHE EFFECT OF PROPOFOL 303
that propofol doses of 0.5 to 1.0 mg/kg briefly affect the canine SO, consistent with the
drug’s rapid redistribution and short half-life. Thus, even if demonstrated to affect the
human SO, propofol may be useful for sedation during SO manometry. Patients not
adequately sedated with diazepam alone could be given small bolus doses of propofol
until successful cannulation is achieved. An interval of several minutes prior to
measuring SO pressures should allow the effects of propofol on the SO to have
resolved.
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